Results 81 to 90 of about 18,294 (178)

XDR-TB: Indian perspective [PDF]

open access: yesEuropean Respiratory Journal, 2007
To the Editors: I read with interest the recent article by Migliori et al. 1 in the March issue of the European Respiratory Journal on the new extensively drug-resistant tuberculosis (XDR-TB) threat, wherein the authors have comprehensively covered the topic and tried to alert the medical fraternity of the need to unite in order to fight this global ...
openaire   +1 more source

XDR of ultradispersed diamonds

open access: yes
XDR of ultradispersed diamonds with nickel ions in paper  Tytarenko V.V., Zabludovsky V.A., Tytarenko I.V. Laser-assisted electrodeposition of composite carbon-containing nickel coatings // Nanosistemi, Nanomateriali, Nanotehnologii, 2024, 22(1), pp. 41-52.
Tytarenko, Valentina   +2 more
openaire   +2 more sources

A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India

open access: yesIndian Journal of Medical Research, 2016
Background & objectives: Pre-extensively drug resistant (pre-XDR) and extensively drug resistant tuberculosis (XDR-TB) have been areas of growing concern, and are posing threat to global efforts of TB control. The present study was planned to study the presence of pre-XDR and XDR Mycobacterium tuberculosis and their ...
Singhal, Parul   +5 more
openaire   +2 more sources

Antimicrobial Resistance Pattern of Acinetobacter baumannii Strains Isolated from Intensive Care Unit Patients

open access: yesMedical Laboratory Journal, 2018
Background and Objectives: Acinetobacter baumannii is an opportunistic pathogen that affects different groups of people, especially intensive care unit (ICU) patients. The prevalence of infections caused by this bacterium is very high.
Azad Khaledi   +4 more
doaj  

Laboratory-confirmed DR, pre-XDR, and XDR-TB cases reported in the Free State, South Africa, from 2019 to 2022, according to previous and updated WHO definitions

open access: yesInternational Journal of Infectious Diseases
Introduction: The global challenge of Tuberculosis (TB) control persists, particularly in addressing drug-resistant (DR) TB across regions. Over time, the rise in rifampicin (RIF/R) resistance, multi-drug resistant TB (MDR-TB, characterised until 2022 by
Miss Zothile Skosana   +2 more
doaj   +1 more source

Resistance to Second-Line Anti-TB Drugs in Cambodia: A Phenotypic and Genetic Study

open access: yesInfection and Drug Resistance, 2021
Sokleaph Cheng,1– 3 Mallorie Hide,3– 5 Sok Heng Pheng,6 Alexandra Kerléguer,2 Gauthier Delvallez,2 Sophan Sam,7 Tan Eang Mao,6 Thi Van Anh Nguyen,3,8 Anne-Laure Bañuls3– 5 1Institut Pasteur du Cambodge and Ministry of ...
Cheng S   +8 more
doaj  

Emergence of an Extensive Drug Resistant Citrobacter portucalensis Clinical Strain Harboring blaSFO-1, blaKPC-2, and blaNDM-1

open access: yesInfection and Drug Resistance
Kexin Guo,1,* Zanzan Zhao,1,* Yu Yang,1 Xiawei Jiang,1 Hao Xu,2 Fangfang Tao,1 Ye Xu,1 Wenhong Liu1 1School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China; 2Collaborative Innovation Center for
Guo K   +7 more
doaj  

Drug-resistant Mycobacterium tuberculosis among Nepalese patients at a tuberculosis referral center.

open access: yesPLoS ONE
BackgroundMultidrug-resistant tuberculosis (MDR-TB), characterized by isoniazid and rifampicin resistance, is caused by chromosomal mutations that restrict treatment options and complicate tuberculosis management.
Arun Bahadur Chand   +7 more
doaj   +1 more source

Treatment outcomes among children and adolescents with extensively drug-resistant (XDR) and pre-XDR tuberculosis: Systematic review and meta-analysis.

open access: yesPLOS Global Public Health
Extensively drug-resistant (XDR) and pre-XDR- tuberculosis (TB) account for approximately a third of pediatric MDR-TB cases globally. Clinical management is challenging; recommendations are based on limited evidence. We assessed the clinical outcomes for
Jayadeep Patra   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy